WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Rizaldy Taslim Pinzon* and Niyata Hananta Karunawan

ABSTRACT

Background: Stroke prevention in AF patients is a very important. One of therapeutic goals is prevention of thromboembolism with anticoagulation. there has been very limited data on pattern of use of antithrombotic therapy for atrial fibrillation patients in southeast Asia. Aim: review the use of antithrombotic therapy pattern for ischemic stroke with atrial fibrillation in in southeast Asia. Methods: We performed a comprehensive search on topic that the pattern of anti-thrombotic use in atrial fibrillation patients with in southeast asia from inception up until November 2019 through PubMed, and Cochrane Central Database. Systematic research process was using various keywords. The keywords were: “anti-thrombotic”, “anti-coagulation”, and “atrial fibrillation', The operator “and” was then used with the name of each country in southeast Asia. The inclusion criteria of the study i.e: patients with AF, was a original papers with observational study, concerned on use of anticoagulation in patients with atrial fibrillation in southeast Asia. Results: Data of using antithrombotic are available in six countries in southeast Asia, a total of the 8 articles identified were from Philippine, Thailand, Vietnam, Singapore, Indonesia, and Malaysia were also represented. The reported The rate of using Anticoagulation for secondary prevention of stroke in southeast Asia is ranged 7.7% to 18.2%. Conclusions: The rate of using Anticoagulation for secondary and primary prevention of stroke in southeast Asia is still low. The Pattern Use of antithrombotic in Stroke Patients with Atrial Fibrillation showed that warfarin is the most widely used Anticoagulation in southeast Asia countries.